AICAR and metformin, but not exercise, increase muscle glucose transport through AMPK-, ERK-, and PDK1-dependent activation of atypical PKC. - Wikidata - awgldk - TriplyDB

AICAR and metformin, but not exercise, increase muscle glucose transport through AMPK-, ERK-, and PDK1-dependent activation of atypical PKC.

AICAR and metformin, but not exercise, increase muscle glucose transport through AMPK-, ERK-, and PDK1-dependent activation of atypical PKC.

http://www.wikidata.org/entity/Q33655490

about

Metabolic regulation of T cell differentiation and function Atypical protein kinase C in cardiometabolic abnormalities Bryostatin modulates latent HIV-1 infection via PKC and AMPK signaling but inhibits acute infection in a receptor independent manner AMP-activated protein kinase plays an important evolutionary conserved role in the regulation of glucose metabolism in fish skeletal muscle cells BECN1-dependent CASP2 incomplete autophagy induction by binding to rabies virus phosphoprotein.Modulation of glucose metabolism by a natural compound from Chloranthus japonicus via activation of AMP-activated protein kinase Quercetin, a Lead Compound against Type 2 Diabetes Ameliorates Glucose Uptake via AMPK Pathway in Skeletal Muscle Cell Line.The effect of 5-aminoimidazole-4-carboxamide-ribonucleoside was mediated by p38 mitogen activated protein kinase signaling pathway in FRO thyroid cancer cells.Effects of exercise on AMPK signaling and downstream components to PI3K in rat with type 2 diabetes.Of mice and men: the benefits of caloric restriction, exercise, and mimetics.Defining the contribution of AMP-activated protein kinase (AMPK) and protein kinase C (PKC) in regulation of glucose uptake by metformin in skeletal muscle cells Contraction stimulates muscle glucose uptake independent of atypical PKC.Porcine circovirus type 2 induces autophagy via the AMPK/ERK/TSC2/mTOR signaling pathway in PK-15 cells Insulin signalling in hepatocytes of humans with type 2 diabetes: excessive production and activity of protein kinase C-ι (PKC-ι) and dependent processes and reversal by PKC-ι inhibitors.Two weeks of metformin treatment induces AMPK-dependent enhancement of insulin-stimulated glucose uptake in mouse soleus muscle.Metabolic functions of atypical protein kinase C: "good" and "bad" as defined by nutritional status.Antihyperglycaemic activity of 2,4:3,5-dibenzylidene-D-xylose-diethyl dithioacetal in diabetic mice.Opposite effects of genistein on the regulation of insulin-mediated glucose homeostasis in adipose tissue Another surprise from Metformin: novel mechanism of action via K-Ras influences endometrial cancer response to therapy.The Effects of Metformin on Obesity-Induced Dysfunctional Retinas Metformin action in human hepatocytes: coactivation of atypical protein kinase C alters 5'-AMP-activated protein kinase effects on lipogenic and gluconeogenic enzyme expression.Current understanding of increased insulin sensitivity after exercise - emerging candidates.Stimulatory Effect of Balanced Deep-Sea Water Containing Chitosan Oligosaccharides on Glucose Uptake in C2C12 Myotubes.Coordinated activation of AMP-activated protein kinase, extracellular signal-regulated kinase, and autophagy regulates phorbol myristate acetate-induced differentiation of SH-SY5Y neuroblastoma cells.Genetic downregulation of AMPK-alpha isoforms uncovers the mechanism by which metformin decreases FA uptake and oxidation in skeletal muscle cells.Involvement of atypical protein kinase C in the regulation of cardiac glucose and long-chain fatty acid uptake.5-Aminoimidazole-4-carboxyamide-1-β-D-ribofranoside stimulates the rat enhancer of split- and hairy-related protein-2 gene via atypical protein kinase C lambda Aspalathin improves glucose and lipid metabolism in 3T3-L1 adipocytes exposed to palmitate.Human mesenchymal stem cell differentiation to the osteogenic or adipogenic lineage is regulated by AMP-activated protein kinase.Genistein represses PEPCK-C expression in an insulin-independent manner in HepG2 cells and in alloxan-induced diabetic mice.Metabolic Regulation of T Cell Immunity.Transcriptional remodeling in response to transfer upon carbon-limited or metformin-supplemented media in S. cerevisiae and its effect on chronological life span.

P2860

Q26798088-4E85E594-B1C8-41B3-B894-711A8C672385 Q27026092-45F119B0-DDC3-4F30-9B33-AC019FBF5748 Q28474468-98D18EE6-550C-4D0E-A10C-72707CBBA5E6 Q28480896-9E4B7572-6E9C-45CD-B0B9-D4D919B3830E Q33553613-3B1B1F63-FB99-4E8D-8136-4CB593705271 Q33677858-E6F4EA25-7C4A-4607-B6CC-1D1793C0196C Q33774651-0D3E24F7-4743-41AC-B19F-38C02C68F70E Q33912895-A17997C9-F8DB-4869-88FA-8E2A57825DC0 Q34525549-2600BA48-C072-4C82-9BA0-00CC8B933F33 Q35973671-744F3ED2-BAAF-4FD5-9C36-28D7A53387EF Q36016832-698458E1-8106-4817-B68B-6C5FA19D4DD2 Q36357480-9AF6127C-BACD-4D95-89BC-753DA0EE4AAF Q36363788-02DE664F-DFDE-4B26-B583-8367980BA678 Q36526711-16F6DD0F-A2EF-400F-B417-6688BC509651 Q37148720-B17F02A0-BF24-41A3-8C7E-F1FFC9BA613C Q37174783-70B05A55-99B6-40D1-92F4-8465D450CF7C Q37294824-3A063F0F-48B0-483E-B2CD-443BDDA64BE6 Q37327382-BC8A140E-5D81-4633-8263-B0D286F88EB0 Q37444285-11EC89AF-9115-46D4-8A4F-9FBDCE64F425 Q37583280-0A486E45-D9B2-41C9-8723-57C0C5BCA485 Q37680132-549E56BA-05C4-4E04-82CF-9A3EACCAA7B9 Q37847244-89AA9DA1-40DC-4AAA-8F46-A09DC656179C Q38769086-D79BF915-5A64-45BC-8F2A-7BFADA5DEAFC Q38944849-708D48C9-7536-40F8-905A-0B3910DA13EE Q39655474-708A6171-C347-4674-B5FF-208188B514AA Q41891892-0C8D005F-4644-49F8-98C7-D65F87812C9F Q42751388-FEE54C0B-28B1-40B2-AB93-7326B5E12DCD Q42823627-90AC001E-12A3-46BE-925C-6FA33752C311 Q43925968-7322AC8D-7389-4671-8780-6DD3F3AF23DB Q48223878-B0B692E3-B4B8-46D3-AD57-E31C4B2F9216 Q50217787-E3407F59-10C4-4891-A333-D10CF23FDDBC Q51619207-BE87DBE3-271B-42EF-A2DD-92F54F7D6164

P2860

AICAR and metformin, but not exercise, increase muscle glucose transport through AMPK-, ERK-, and PDK1-dependent activation of atypical PKC.

http://www.wikidata.org/entity/Q33655490

description

2009 nî lūn-bûn

@nan

2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

AICAR and metformin, but not e ...... nt activation of atypical PKC.

@ast

AICAR and metformin, but not e ...... nt activation of atypical PKC.

@en

type

label

AICAR and metformin, but not e ...... nt activation of atypical PKC.

@ast

AICAR and metformin, but not e ...... nt activation of atypical PKC.

@en

prefLabel

AICAR and metformin, but not e ...... nt activation of atypical PKC.

@ast

AICAR and metformin, but not e ...... nt activation of atypical PKC.

@en

P1433

Q33655490-AD09F067-A124-46BD-83A8-476C0E9A4E02

P1476

Q33655490-841FE5E7-F36B-4E1A-A948-533F62BA82BD

P2093

Q33655490-89709FE4-60FF-47F6-885B-F14EBE412882

Q33655490-8F7348EE-7A96-44A1-A2A4-434FEAFE8B32

Q33655490-9C8B8737-E258-4319-8F53-4E1F225B0D28

Q33655490-B3864AC2-B446-4358-A1C2-AF8D2E63DF42

Q33655490-BFB7B535-08BC-4A98-A203-447449514DF9

Q33655490-C9AF8A1C-03C0-4DD6-BA97-4847589AC67C

Q33655490-CE1B89AB-C228-4694-BCB9-A3A014996779

Q33655490-CE3B072C-398A-408D-A2FC-DAD8DF3CD720

Q33655490-DB24368B-8FAF-490D-8197-3086339CD07C

Q33655490-F4C68D74-0B4E-4D9E-B49C-8CC007B5F7F3

P2860

Q33655490-0038F615-8C47-40CE-B126-C062F21522A7

Q33655490-009DF697-2A4B-4D3D-9044-A9F6937D9D5B

Q33655490-06A224A4-C7EA-4525-8E9F-833815F7EACD

Q33655490-0CD13D24-D6E8-4869-B391-79B1AB3BA860

Q33655490-0E939670-3B3F-420F-AE3D-336E0FBAE7E9

Q33655490-0F879A0B-608B-47E0-B897-F5C81077D3A5

Q33655490-1780CD18-4F6A-40EF-920F-DEABE1D2307B

Q33655490-2C747652-3B86-4533-AA74-DA36ED04CC16

Q33655490-2D35F838-C00C-4A37-A61D-BB0A527AFDE6

Q33655490-38F9ED48-9689-4BD4-A010-7849C12B0F0E

P304

Q33655490-75D91166-FF04-4F8E-92C7-727FBA59B94E

P31

Q33655490-2CD0ED90-68EF-4B95-92EB-B26B7B354630

P356

Q33655490-305F379C-C126-4B30-8E38-59F502B98316

P433

Q33655490-E3377271-78E1-41FE-9D84-EF5DD14A6141

P478

Q33655490-94C96149-46C9-401F-9CD3-C9C7FA73AD66

P50

Q33655490-5C0EA41A-F2EB-49F3-AFA4-473B1F308AC0

Q33655490-D955E99B-0A77-4004-8693-FAB96DF7A674

P577

Q33655490-0A114D7F-FA72-492D-AB64-841D5F1DA145

P698

Q33655490-9A162CC3-0413-47B9-8AF2-C6E7641568CB

P921

Q33655490-DC3D9BF8-9212-4EC2-93F0-D52099E12968

P932

Q33655490-4A25C4BE-9CAE-4D45-BD68-C7C335C70115

P356

AJPENDO.00392.2009

P1433

American Journal of Physiology - Endocrinology and Metabolism

P1476

AICAR and metformin, but not e ...... ent activation of atypical PKC

@en

P2093

A Miura

http://www.w3.org/2001/XMLSchema#string

E Van Obberghen

http://www.w3.org/2001/XMLSchema#string

G Bandyopadhyay

http://www.w3.org/2001/XMLSchema#string

I Hainault

http://www.w3.org/2001/XMLSchema#string

M L Standaert

http://www.w3.org/2001/XMLSchema#string

M Leitges

http://www.w3.org/2001/XMLSchema#string

M P Sajan

http://www.w3.org/2001/XMLSchema#string

R Kahn

http://www.w3.org/2001/XMLSchema#string

R V Farese

http://www.w3.org/2001/XMLSchema#string

S Nimal

http://www.w3.org/2001/XMLSchema#string

P2860

Metformin Increases AMP-Activated Protein Kinase Activity in Skeletal Muscle of Subjects With Type 2 Diabetes

Role of AMP-activated protein kinase in mechanism of metformin action

Protein tyrosine kinase PYK2 involved in Ca(2+)-induced regulation of ion channel and MAP kinase functions

Isoform-specific and exercise intensity-dependent activation of 5'-AMP-activated protein kinase in human skeletal muscle

AMPK and PPARdelta agonists are exercise mimetics

Adaptor proteins Grb2 and Crk couple Pyk2 with activation of specific mitogen-activated protein kinase cascades

PKC-zeta mediates insulin effects on glucose transport in cultured preadipocyte-derived human adipocytes

Src and Pyk2 mediate G-protein-coupled receptor activation of epidermal growth factor receptor (EGFR) but are not required for coupling to the mitogen-activated protein (MAP) kinase signaling cascade

PKClambda in liver mediates insulin-induced SREBP-1c expression and determines both hepatic lipid content and overall insulin sensitivity

Characterization of the role of AMP-activated protein kinase in the regulation of glucose-activated gene expression using constitutively active and dominant negative forms of the kinase.

P304

E179-92

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1152/AJPENDO.00392.2009

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

298

http://www.w3.org/2001/XMLSchema#string

P50

Fabienne Foufelle

P577

2009-11-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19887597

http://www.w3.org/2001/XMLSchema#string

P921

P932

2822478

http://www.w3.org/2001/XMLSchema#string